Neurobiology of microglial action in CNS injuries: Receptor-mediated signaling mechanisms and functional roles

Progress in Neurobiology

Volumn 119-120, Issue , 2014, Pages 60-84

  Hu, Xiaoming ^a,b,c   Liou, Anthony K F ^a   Leak, Rehana K ^d   Xu, Mingyue ^b   An, Chengrui ^b   Suenaga, Jun ^a   Shi, Yejie ^a   Gao, Yanqin ^b   Zheng, Ping ^b   Chen, Jun ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUQUESNE UNIVERSITY   (United States)

Author keywords

Central nervous system injuries; Microglia; Receptor

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR; CD200 RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; FC RECEPTOR; FRACTALKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN SUPERFAMILY; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLSERINE; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y2 RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 3; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR; PHOSPHATIDYLSERINE RECEPTOR; PURINERGIC RECEPTOR;

ACTIN FILAMENT; BONE MARROW CELL; CELL ACTIVATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; MICROGLIA; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM INJURY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CENTRAL NERVOUS SYSTEM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MICROGLIA; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; RECEPTORS, PATTERN RECOGNITION; RECEPTORS, PURINERGIC; TRAUMA, NERVOUS SYSTEM;

EID: 84905373642     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2014.06.002     Document Type: Review

References (353)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7947-7952.
2. Adami C., Bianchi R., Pula G., Donato R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta 2004, 1742:169-177.
3. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998, 188:1359-1368.
4. Angulo E., Casado V., Mallol J., Canela E.I., Vinals F., Ferrer I., Lluis C., Franco R. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 2003, 13:440-451.
5. Arai H., Charo I.F. Differential regulation of G-protein-mediated signaling by chemokine receptors. J. Biol. Chem. 1996, 271:21814-21819.
6. Arumugam T.V., Tang S.C., Lathia J.D., Cheng A., Mughal M.R., Chigurupati S., Magnus T., Chan S.L., Jo D.G., Ouyang X., Fairlie D.P., Granger D.N., Vortmeyer A., Basta M., Mattson M.P. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14104-14109.
7. Asensio V.C., Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 1999, 22:504-512.
8. Babcock A.A., Kuziel W.A., Rivest S., Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 2003, 23:7922-7930.
9. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 2003, 23:2665-2674.
10. Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostene W., Melik Parsadaniantz S. Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci. 2002, 16:1661-1671.
11. Banisadr G., Queraud-Lesaux F., Boutterin M.C., Pelaprat D., Zalc B., Rostene W., Haour F., Parsadaniantz S.M. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J. Neurochem. 2002, 81:257-269.
12. Bao Y., Kim E., Bhosle S., Mehta H., Cho S. A role for spleen monocytes in post-ischemic brain inflammation and injury. J. Neuroinflammation 2010, 7:92.
13. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 2000, 6:916-919.
14. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19:819-834.
15. Barrow A.D., Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur. J. Immunol. 2006, 36:1646-1653.
16. Beer C., Blacker D., Hankey G.J., Puddey I.B. Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: a cross-sectional observational study. Med. Sci. Monit. 2011, 17:CR467-CR473.
17. Beggs S., Trang T., Salter M.W. P2X4R+ microglia drive neuropathic pain. Nat. Neurosci. 2012, 15:1068-1073.
18. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
19. Bhaskar K., Konerth M., Kokiko-Cochran O.N., Cardona A., Ransohoff R.M., Lamb B.T. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 2010, 68:19-31.
20. Bianchi R., Adami C., Giambanco I., Donato R. S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 2007, 81:108-118.
21. Bianchi R., Giambanco I., Donato R. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol. Aging 2010, 31:665-677.
22. Bianchi R., Kastrisianaki E., Giambanco I., Donato R. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J. Biol. Chem. 2011, 286:7214-7226.
23. Bianco F., Ceruti S., Colombo A., Fumagalli M., Ferrari D., Pizzirani C., Matteoli M., Di Virgilio F., Abbracchio M.P., Verderio C. A role for P2X7 in microglial proliferation. J. Neurochem. 2006, 99:745-758.
24. Bianco F., Pravettoni E., Colombo A., Schenk U., Moller T., Matteoli M., Verderio C. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 2005, 174:7268-7277.
25. Biber K., Dijkstra I., Trebst C., De Groot C.J., Ransohoff R.M., Boddeke H.W. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 2002, 112:487-497.
26. Biber K., Neumann H., Inoue K., Boddeke H.W. Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci. 2007, 30:596-602.
27. Biber K., Sauter A., Brouwer N., Copray S.C., Boddeke H.W. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia 2001, 34:121-133.
28. Biber K., Tsuda M., Tozaki-Saitoh H., Tsukamoto K., Toyomitsu E., Masuda T., Boddeke H., Inoue K. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J. 2011, 30:1864-1873.
29. Binder M.D., Cate H.S., Prieto A.L., Kemper D., Butzkueven H., Gresle M.M., Cipriani T., Jokubaitis V.G., Carmeliet P., Kilpatrick T.J. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J. Neurosci. 2008, 28:5195-5206.
30. Binder M.D., Xiao J., Kemper D., Ma G.Z., Murray S.S., Kilpatrick T.J. Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination. PLoS ONE 2011, 6:e17727.
31. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
32. Boddeke E.W., Meigel I., Frentzel S., Gourmala N.G., Harrison J.K., Buttini M., Spleiss O., Gebicke-Harter P. Cultured rat microglia express functional beta-chemokine receptors. J. Neuroimmunol. 1999, 98:176-184.
33. Bonacchi A., Romagnani P., Romanelli R.G., Efsen E., Annunziato F., Lasagni L., Francalanci M., Serio M., Laffi G., Pinzani M., Gentilini P., Marra F. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem. 2001, 276:9945-9954.
34. Borisenko G.G., Matsura T., Liu S.X., Tyurin V.A., Jianfei J., Serinkan F.B., Kagan V.E. Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells - existence of a threshold. Arch. Biochem. Biophys. 2003, 413:41-52.
35. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000, 164:4991-4995.
36. Brunette R.L., Young J.M., Whitley D.G., Brodsky I.E., Malik H.S., Stetson D.B. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J. Exp. Med. 2012, 209:1969-1983.
37. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
38. Buell G., Lewis C., Collo G., North R.A., Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 1996, 15:55-62.
39. Bune L.T., Thaning P., Johansson P.I., Bochsen L., Rosenmeier J.B. Effects of nucleotides and nucleosides on coagulation. Blood Coagul. Fibrinolysis 2010, 21:436-441.
40. Butchi N.B., Du M., Peterson K.E. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 2010, 58:650-664.
41. Butt A.M. ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin. Cell Dev. Biol. 2011, 22:205-213.
42. Cambien B., Pomeranz M., Schmid-Antomarchi H., Millet M.A., Breittmayer V., Rossi B., Schmid-Alliana A. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 2001, 97:2031-2037.
43. Carbonell W.S., Murase S., Horwitz A.F., Mandell J.W. Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study. J. Neurosci. 2005, 25:7040-7047.
44. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
45. Cartier L., Dubois-Dauphin M., Hartley O., Irminger-Finger I., Krause K.H. Chemokine-induced cell death in CCR5-expressing neuroblastoma cells. J. Neuroimmunol. 2003, 145:27-39.
46. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599-1608.
47. Cavaliere F., Florenzano F., Amadio S., Fusco F.R., Viscomi M.T., D'Ambrosi N., Vacca F., Sancesario G., Bernardi G., Molinari M., Volonte C. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 2003, 120:85-98.
48. Charo I.F., Myers S.J., Herman A., Franci C., Connolly A.J., Coughlin S.R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2752-2756.
49. Chen B.P., Kuziel W.A., Lane T.E. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J. Immunol. 2001, 167:4585-4592.
50. Chen J., Connor K.M., Smith L.E. Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration. J. Clin. Invest. 2007, 117:2758-2762.
51. Chen J.F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M.A., Fink J.S., Schwarzschild M.A. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 1999, 19:9192-9200.
52. Cho S.H., Sun B., Zhou Y., Kauppinen T.M., Halabisky B., Wes P., Ransohoff R.M., Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 2011, 286:32713-32722.
53. Choi I.Y., Lee J.C., Ju C., Hwang S., Cho G.S., Lee H.W., Choi W.J., Jeong L.S., Kim W.K. A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am. J. Pathol. 2011, 179:2042-2052.
54. Chu K., Yin B., Wang J., Peng G., Liang H., Xu Z., Du Y., Fang M., Xia Q., Luo B. Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus. J. Neuroinflammation 2012, 9:69.
55. Chung L.Y., Tang S.J., Sun G.H., Chou T.Y., Yeh T.S., Yu S.L., Sun K.H. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin. Cancer Res. 2012, 18:4037-4047.
56. Clark-Lewis I., Mattioli I., Gong J.H., Loetscher P. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J. Biol. Chem. 2003, 278:289-295.
57. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F., Dehvari M., Wotherspoon G., Winter J., Ullah J., Bevan S., Malcangio M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10655-10660.
58. Clark A.K., Yip P.K., Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J. Neurosci. 2009, 29:6945-6954.
59. Copland D.A., Calder C.J., Raveney B.J., Nicholson L.B., Phillips J., Cherwinski H., Jenmalm M., Sedgwick J.D., Dick A.D. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 2007, 171:580-588.
60. Coraci I.S., Husemann J., Berman J.W., Hulette C., Dufour J.H., Campanella G.K., Luster A.D., Silverstein S.C., El-Khoury J.B. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 2002, 160:101-112.
61. Cortegano I., Pozo V., Cardaba B., Arrieta I., Gallardo S., Rojo M., Aceituno E., Takai T., Verbeek S., Palomino P., Liu F.T., Lahoz C. Interaction between galectin-3 and FcgammaRII induces down-regulation of IL-5 gene: implication of the promoter sequence IL-5REIII. Glycobiology 2000, 10:237-242.
62. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
63. Cowell R.M., Xu H., Parent J.M., Silverstein F.S. Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia-ischemia. J. Neuroimmunol. 2006, 173:155-165.
64. Crain J.M., Nikodemova M., Watters J.J. Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia. J. Neuroinflammation 2009, 6:24.
65. Crowley M.T., Costello P.S., Fitzer-Attas C.J., Turner M., Meng F., Lowell C., Tybulewicz V.L., DeFranco A.L. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J. Exp. Med. 1997, 186:1027-1039.
66. Cucchiarini M., Ren X.L., Perides G., Terwilliger E.F. Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors. Gene Ther. 2003, 10:657-667.
67. D'Mello C., Le T., Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 2009, 29:2089-2102.
68. Dai S.S., Li W., An J.H., Wang H., Yang N., Chen X.Y., Zhao Y., Li P., Liu P., Chen J.F., Zhou Y.G. Adenosine A2A receptors in both bone marrow cells and non-bone marrow cells contribute to traumatic brain injury. J. Neurochem. 2010, 113:1536-1544.
69. Dascal N. Ion-channel regulation by G proteins. Trends Endocrinol. Metab. 2001, 12:391-398.
70. de Jong E.K., de Haas A.H., Brouwer N., van Weering H.R., Hensens M., Bechmann I., Pratley P., Wesseling E., Boddeke H.W., Biber K. Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. J. Neurochem. 2008, 105:1726-1736.
71. de Jong E.K., Dijkstra I.M., Hensens M., Brouwer N., van Amerongen M., Liem R.S., Boddeke H.W., Biber K. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci. 2005, 25:7548-7557.
72. De S.R., Ajmone-Cat M.A., Nicolini A., Minghetti L. Expression of phosphatidylserine receptor and down-regulation of pro-inflammatory molecule production by its natural ligand in rat microglial cultures. J. Neuropathol. Exp. Neurol. 2002, 61:237-244.
73. Denes A., Ferenczi S., Halasz J., Kornyei Z., Kovacs K.J. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 2008, 28:1707-1721.
74. Deng Y.Y., Lu J., Ling E.A., Kaur C. Monocyte chemoattractant protein-1 (MCP-1) produced via NF-kappaB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats. Glia 2009, 57:604-621.
75. Desforges N.M., Hebron M.L., Algarzae N.K., Lonskaya I., Moussa C.E. Fractalkine mediates communication between pathogenic proteins and microglia: implications of anti-inflammatory treatments in different stages of neurodegenerative diseases. Int. J. Alzheimers Dis. 2012, 2012:345472.
76. Dijkstra I.M., Hulshof S., van der Valk P., Boddeke H.W., Biber K. Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21. J. Immunol. 2004, 172:2744-2747.
77. Dimitrijevic O.B., Stamatovic S.M., Keep R.F., Andjelkovic A.V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007, 38:1345-1353.
78. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
79. Donnelly D.J., Longbrake E.E., Shawler T.M., Kigerl K.A., Lai W., Tovar C.A., Ransohoff R.M., Popovich P.G. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J. Neurosci. 2011, 31:9910-9922.
80. Dukic-Stefanovic S., Gasic-Milenkovic J., Deuther-Conrad W., Munch G. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J. Neurochem. 2003, 87:44-55.
81. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13632-13637.
82. Engel T., Gomez-Villafuertes R., Tanaka K., Mesuret G., Sanz-Rodriguez A., Garcia-Huerta P., Miras-Portugal M.T., Henshall D.C., Diaz-Hernandez M. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J. 2012, 26:1616-1628.
83. Eugenin E.A., Osiecki K., Lopez L., Goldstein H., Calderon T.M., Berman J.W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 2006, 26:1098-1106.
84. Fadok V.A., Bratton D.L., Frasch S.C., Warner M.L., Henson P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998, 5:551-562.
85. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405:85-90.
86. Fang F., Lue L.F., Yan S., Xu H., Luddy J.S., Chen D., Walker D.G., Stern D.M., Schmidt A.M., Chen J.X., Yan S.S. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J. 2010, 24:1043-1055.
87. Faustino J.V., Wang X., Johnson C.E., Klibanov A., Derugin N., Wendland M.F., Vexler Z.S. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J. Neurosci. 2011, 31:12992-13001.
88. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Collo G., Buell G., Di Virgilio F. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 1997, 36:1295-1301.
89. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Melchiorri L., Baricordi O.R., Di Virgilio F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 1997, 159:1451-1458.
90. Ferrari D., Chiozzi P., Falzoni S., Hanau S., Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 1997, 185:579-582.
91. Ferrari D., Los M., Bauer M.K., Vandenabeele P., Wesselborg S., Schulze-Osthoff K. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 1999, 447:71-75.
92. Ferrari D., Villalba M., Chiozzi P., Falzoni S., Ricciardi-Castagnoli P., Di Virgilio F. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 1996, 156:1531-1539.
93. Ferrari D., Wesselborg S., Bauer M.K., Schulze-Osthoff K. Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J. Cell Biol. 1997, 139:1635-1643.
94. Fiebich B.L., Biber K., Lieb K., van Calker D., Berger M., Bauer J., Gebicke-Haerter P.J. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia 1996, 18:152-160.
95. Fleit H.B., Kobasiuk C.D., Daly C., Furie R., Levy P.C., Webster R.O. A soluble form of Fc gamma RIII is present in human serum and other body fluids and is elevated at sites of inflammation. Blood 1992, 79:2721-2728.
96. Flynn G., Maru S., Loughlin J., Romero I.A., Male D. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 2003, 136:84-93.
97. Franci C., Wong L.M., Van Damme J., Proost P., Charo I.F. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J. Immunol. 1995, 154:6511-6517.
98. Frank S., Burbach G.J., Bonin M., Walter M., Streit W., Bechmann I., Deller T. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 2008, 56:1438-1447.
99. Franke H., Gunther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., Faber-Zuschratter H., Schneider D., Illes P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 2004, 63:686-699.
100. Fuller A.D., Van Eldik L.J. MFG-E8 regulates microglial phagocytosis of apoptotic neurons. J. Neuroimmune Pharmacol. 2008, 3:246-256.
101. Galasso J.M., Harrison J.K., Silverstein F.S. Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am. J. Pathol. 1998, 153:1631-1640.
102. Galon J., Gauchat J.F., Mazieres N., Spagnoli R., Storkus W., Lotze M., Bonnefoy J.Y., Fridman W.H., Sautes C. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J. Immunol. 1996, 157:1184-1192.
103. Gamo K., Kiryu-Seo S., Konishi H., Aoki S., Matsushima K., Wada K., Kiyama H. G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J. Neurosci. 2008, 28:11980-11988.
104. Gao T.L., Yuan X.T., Yang D., Dai H.L., Wang W.J., Peng X., Shao H.J., Jin Z.F., Fu Z.J. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury. J. Trauma Acute Care Surg. 2012, 72:643-649.
105. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., Sarafi M.N., Lavigne F., Hamid Q., Murphy P.M., Luster A.D. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 1996, 157:5613-5626.
106. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., Bratton D.L., Oldenborg P.A., Michalak M., Henson P.M. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005, 123:321-334.
107. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., Raines E.W. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 2001, 276:37993-38001.
108. Gebicke-Haerter P.J., Christoffel F., Timmer J., Northoff H., Berger M., Van Calker D. Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem. Int. 1996, 29:37-42.
109. Gendron F.P., Chalimoniuk M., Strosznajder J., Shen S., Gonzalez F.A., Weisman G.A., Sun G.Y. P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 2003, 87:344-352.
110. Genovese T., Melani A., Esposito E., Mazzon E., Di Paola R., Bramanti P., Pedata F., Cuzzocrea S. The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord. Shock 2009, 32:578-585.
111. Getts D.R., Terry R.L., Getts M.T., Muller M., Rana S., Shrestha B., Radford J., Van Rooijen N., Campbell I.L., King N.J. Ly6c+ inflammatory monocytes are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 2008, 205:2319-2337.
112. Gibot S., Kolopp-Sarda M.N., Bene M.C., Bollaert P.E., Lozniewski A., Mory F., Levy B., Faure G.C. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 2004, 200:1419-1426.
113. Giri R., Shen Y., Stins M., Du Yan S., Schmidt A.M., Stern D., Kim K.S., Zlokovic B., Kalra V.K. Beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 2000, 279:C1772-C1781.
114. Gong Q.J., Li Y.Y., Xin W.J., Zang Y., Ren W.J., Wei X.H., Zhang T., Liu X.G. ATP induces long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia. Glia 2009, 57:583-591.
115. Gresham H.D., Dale B.M., Potter J.W., Chang P.W., Vines C.M., Lowell C.A., Lagenaur C.F., Willman C.L. Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr. J. Exp. Med. 2000, 191:515-528.
116. Grommes C., Lee C.Y., Wilkinson B.L., Jiang Q., Koenigsknecht-Talboo J.L., Varnum B., Landreth G.E. Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J. Neuroimmune Pharmacol. 2008, 3:130-140.
117. Gross B.S., Lee J.R., Clements J.L., Turner M., Tybulewicz V.L., Findell P.R., Koretzky G.A., Watson S.P. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J. Biol. Chem. 1999, 274:5963-5971.
118. Gudipaty L., Munetz J., Verhoef P.A., Dubyak G.R. Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. Cell Physiol. 2003, 285:C286-C299.
119. Hammarberg C., Fredholm B.B., Schulte G. Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3'-kinase. Biochem. Pharmacol. 2004, 67:129-134.
120. Hammarberg C., Schulte G., Fredholm B.B. Evidence for functional adenosine A3 receptors in microglia cells. J. Neurochem. 2003, 86:1051-1054.
121. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002, 417:182-187.
122. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
123. Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 2011, 121:367-387.
124. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
125. Hasko G., Pacher P. Regulation of macrophage function by adenosine. Arterioscler. Thromb. Vasc. Biol. 2012, 32:865-869.
126. Hasko G., Pacher P., Vizi E.S., Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci. 2005, 26:511-516.
127. Hatherley D., Barclay A.N. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur. J. Immunol. 2004, 34:1688-1694.
128. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 2006, 9:1512-1519.
129. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C.R., Sodroski J., Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
130. He W.J., Cui J., Du L., Zhao Y.D., Burnstock G., Zhou H.D., Ruan H.Z. Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model. Behav. Brain Res. 2012, 226:163-170.
131. Headrick J.P., Bendall M.R., Faden A.I., Vink R. Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: potential role in secondary injury. J. Cereb. Blood Flow Metab. 1994, 14:853-861.
132. Heldmann U., Mine Y., Kokaia Z., Ekdahl C.T., Lindvall O. Selective depletion of Mac-1-expressing microglia in rat subventricular zone does not alter neurogenic response early after stroke. Exp. Neurol. 2011, 229:391-398.
133. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 2000, 18:709-737.
134. Hide I., Tanaka M., Inoue A., Nakajima K., Kohsaka S., Inoue K., Nakata Y. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem. 2000, 75:965-972.
135. Hill W.D., Hess D.C., Martin-Studdard A., Carothers J.J., Zheng J., Hale D., Maeda M., Fagan S.C., Carroll J.E., Conway S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 2004, 63:84-96.
136. Hirt U.A., Leist M. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ. 2003, 10:1156-1164.
137. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
138. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
139. Horvath R.J., DeLeo J.A. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J. Neurosci. 2009, 29:998-1005.
140. Hsieh C.L., Koike M., Spusta S.C., Niemi E.C., Yenari M., Nakamura M.C., Seaman W.E. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 2009, 109:1144-1156.
141. Hu J.H., Yang J.P., Liu L., Li C.F., Wang L.N., Ji F.H., Cheng H. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord. Brain Res. 2012, 1465:1-9.
142. Hua F., Ma J., Ha T., Xia Y., Kelley J., Williams D.L., Kao R.L., Browder I.W., Schweitzer J.B., Kalbfleisch J.H., Li C. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 2007, 190:101-111.
143. Huang Z.Y., Hunter S., Kim M.K., Indik Z.K., Schreiber A.D. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA. J. Leukoc. Biol. 2003, 73:823-829.
144. Hudson B.I., Bucciarelli L.G., Wendt T., Sakaguchi T., Lalla E., Qu W., Lu Y., Lee L., Stern D.M., Naka Y., Ramasamy R., Yan S.D., Yan S.F., D'Agati V., Schmidt A.M. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch. Biochem. Biophys. 2003, 419:80-88.
145. Hudson B.I., Carter A.M., Harja E., Kalea A.Z., Arriero M., Yang H., Grant P.J., Schmidt A.M. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 2008, 22:1572-1580.
146. Huizinga T.W., de Haas M., Kleijer M., Nuijens J.H., Roos D., von dem Borne A.E. Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J. Clin. Invest. 1990, 86:416-423.
147. Hundhausen C., Misztela D., Berkhout T.A., Broadway N., Saftig P., Reiss K., Hartmann D., Fahrenholz F., Postina R., Matthews V., Kallen K.J., Rose-John S., Ludwig A. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003, 102:1186-1195.
148. Husemann J., Loike J.D., Anankov R., Febbraio M., Silverstein S.C. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002, 40:195-205.
149. Imai F., Suzuki H., Oda J., Ninomiya T., Ono K., Sano H., Sawada M. Neuroprotective effect of exogenous microglia in global brain ischemia. J. Cereb. Blood Flow Metab. 2007, 27:488-500.
150. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.
151. Irino Y., Nakamura Y., Inoue K., Kohsaka S., Ohsawa K. Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. J. Neurosci. Res. 2008, 86:1511-1519.
152. Ivashkiv L.B. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 2009, 10:340-347.
153. Jakus Z., Simon E., Frommhold D., Sperandio M., Mocsai A. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. J. Exp. Med. 2009, 206:577-593.
154. James G., Butt A.M. P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 2002, 447:247-260.
155. Jaremo P., Eriksson M., Lindahl T.L., Nilsson S., Milovanovic M. Platelets and acute cerebral infarction. Platelets 2013, 24:407-411.
156. Jeon S.B., Yoon H.J., Park S.H., Kim I.H., Park E.J. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J. Immunol. 2008, 181:8077-8087.
157. Juranyi Z., Sperlagh B., Vizi E.S. Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res. 1999, 823:183-190.
158. Kahlenberg J.M., Dubyak G.R. Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am. J. Physiol. Cell Physiol. 2004, 286:C1100-C1108.
159. Kataoka A., Tozaki-Saitoh H., Koga Y., Tsuda M., Inoue K. Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J. Neurochem. 2009, 108:115-125.
160. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
161. Khazaei M.R., Habibi-Rezaei M., Karimzadeh F., Moosavi-Movahedi A.A., Sarrafnejhad A.A., Sabouni F., Bakhti M. Microglial cell death induced by glycated bovine serum albumin: nitric oxide involvement. J. Biochem. 2008, 144:197-206.
162. Kiialainen A., Hovanes K., Paloneva J., Kopra O., Peltonen L. Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol. Dis. 2005, 18:314-322.
163. Kilic U., Kilic E., Matter C.M., Bassetti C.L., Hermann D.M. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol. Dis. 2008, 31:33-40.
164. Kim B., Jeong H.K., Kim J.H., Lee S.Y., Jou I., Joe E.H. Uridine 5'-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. J. Immunol. 2011, 186:3701-3709.
165. Kim G.H., Kellner C.P., Hahn D.K., Desantis B.M., Musabbir M., Starke R.M., Rynkowski M., Komotar R.J., Otten M.L., Sciacca R., Schmidt J.M., Mayer S.A., Connolly E.S. Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2008, 109:38-43.
166. Klesney-Tait J., Turnbull I.R., Colonna M. The TREM receptor family and signal integration. Nat. Immunol. 2006, 7:1266-1273.
167. Kobayashi N., Karisola P., Pena-Cruz V., Dorfman D.M., Jinushi M., Umetsu S.E., Butte M.J., Nagumo H., Chernova I., Zhu B., Sharpe A.H., Ito S., Dranoff G., Kaplan G.G., Casasnovas J.M., Umetsu D.T., Dekruyff R.H., Freeman G.J. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007, 27:927-940.
168. Koh H.S., Lee C., Lee K.S., Ham C.S., Seong R.H., Kim S.S., Jeon S.H. CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-kappaB upon T-cell activation. Biochem. Biophys. Res. Commun. 2008, 370:149-153.
169. Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., Joshi B.V., Jacobson K.A., Kohsaka S., Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095.
170. Komine-Kobayashi M., Chou N., Mochizuki H., Nakao A., Mizuno Y., Urabe T. Dual role of Fcgamma receptor in transient focal cerebral ischemia in mice. Stroke 2004, 35:958-963.
171. Koos B.J., Kruger L., Murray T.F. Source of extracellular brain adenosine during hypoxia in fetal sheep. Brain Res. 1997, 778:439-442.
172. Krieger M. Charting the fate of the good cholesterol: identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 1999, 68:523-558.
173. Kwon M.J., Kim J., Shin H., Jeong S.R., Kang Y.M., Choi J.Y., Hwang D.H., Kim B.G. Contribution of macrophages to enhanced regenerative capacity of dorsal root ganglia sensory neurons by conditioning injury. J. Neurosci. 2013, 33:15095-15108.
174. Lalancette-Hebert M., Gowing G., Simard A., Weng Y.C., Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 2007, 27:2596-2605.
175. Lalancette-Hebert M., Swarup V., Beaulieu J.M., Bohacek I., Abdelhamid E., Weng Y.C., Sato S., Kriz J. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J. Neurosci. 2012, 32:10383-10395.
176. Latini S., Corsi C., Pedata F., Pepeu G. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem. Int. 1996, 28:113-118.
177. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 2001, 79:463-484.
178. Le W., Rowe D., Xie W., Ortiz I., He Y., Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 2001, 21:8447-8455.
179. Lech M., Avila-Ferrufino A., Skuginna V., Susanti H.E., Anders H.J. Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int. Immunol. 2010, 22:717-728.
180. Lee J.Y., Jhun B.S., Oh Y.T., Lee J.H., Choe W., Baik H.H., Ha J., Yoon K.S., Kim S.S., Kang I. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells. Neurosci. Lett. 2006, 396:1-6.
181. Lee S., Varvel N.H., Konerth M.E., Xu G., Cardona A.E., Ransohoff R.M., Lamb B.T. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 2010, 177:2549-2562.
182. Lee S.J., Lee S. Toll-like receptors and inflammation in the CNS. Curr. Drug Targets Inflamm. Allergy 2002, 1:181-191.
183. Lehnardt S., Lehmann S., Kaul D., Tschimmel K., Hoffmann O., Cho S., Krueger C., Nitsch R., Meisel A., Weber J.R. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 2007, 190:28-33.
184. Lendvai N., Qu X.W., Hsueh W., Casadevall A. Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. J. Immunol. 2000, 164:4367-4374.
185. Leonardi-Essmann F., Emig M., Kitamura Y., Spanagel R., Gebicke-Haerter P.J. Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia. J. Neuroimmunol. 2005, 160:92-101.
186. Li E., Noda M., Doi Y., Parajuli B., Kawanokuchi J., Sonobe Y., Takeuchi H., Mizuno T., Suzumura A. The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid beta toxicity. J. Neuroinflammation 2012, 9:148.
187. Li F., Wang L., Li J.W., Gong M., He L., Feng R., Dai Z., Li S.Q. Hypoxia induced amoeboid microglial cell activation in postnatal rat brain is mediated by ATP receptor P2X4. BMC Neurosci. 2011, 12:111.
188. Li H., Gang Z., Yuling H., Luokun X., Jie X., Hao L., Li W., Chunsong H., Junyan L., Mingshen J., Youxin J., Feili G., Boquan J., Jinquan T. Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia. J. Immunol. 2006, 177:3644-3656.
189. Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., Eusebi F. SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 2000, 12:2497-2504.
190. Linnartz B., Neumann H. Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. Glia 2013, 61:37-46.
191. Liu F.T. Galectins: novel anti-inflammatory drug targets. Expert Opin. Ther. Targets 2002, 6:461-468.
192. Liu Z., Condello C., Schain A., Harb R., Grutzendler J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J. Neurosci. 2010, 30:17091-17101.
193. Liu Z., Fan Y., Won S.J., Neumann M., Hu D., Zhou L., Weinstein P.R., Liu J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007, 38:146-152.
194. Lu D.Y., Tang C.H., Yeh W.L., Wong K.L., Lin C.P., Chen Y.H., Lai C.H., Chen Y.F., Leung Y.M., Fu W.M. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur. J. Pharmacol. 2009, 613:146-154.
195. Lue L.F., Walker D.G. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide. J. Neurosci. Res. 2002, 70:599-610.
196. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., Stern D.M., Yan S.D. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 2001, 171:29-45.
197. Lyons A., Downer E.J., Crotty S., Nolan Y.M., Mills K.H., Lynch M.A. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J. Neurosci. 2007, 27:8309-8313.
198. Lyons A., Lynch A.M., Downer E.J., Hanley R., O'Sullivan J.B., Smith A., Lynch M.A. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attenuates microglial activation in vivo and in vitro. J. Neurochem. 2009, 110:1547-1556.
199. Ma X.J., Cheng J.W., Zhang J., Liu A.J., Liu W., Guo W., Shen F.M., Lu G.C. E-selectin deficiency attenuates brain ischemia in mice. CNS Neurosci. Ther. 2012, 18:903-908.
200. Marella M., Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 2004, 24:620-627.
201. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Takahashi H., Imai Y., Tanaka J. Expression of CD200 by macrophage-like cells in ischemic core of rat brain after transient middle cerebral artery occlusion. Neurosci. Lett. 2007, 418:44-48.
202. Merino J.J., Gutierrez-Fernandez M., Rodriguez-Frutos B., Alvarez-Grech J., Alcalde M.E., Vallejo-Cremades M.T., Diez-Tejedor E. CXCR4/SDF-1alpha-chemokine regulates neurogenesis and/or angiogenesis within the vascular niche of ischemic rats; however, does SDF-1alpha play a role in repair?. Int. J. Stroke 2011, 6:466-467.
203. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14500-14505.
204. Mihrshahi R., Barclay A.N., Brown M.H. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 2009, 183:4879-4886.
205. Mihrshahi R., Brown M.H. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. J. Immunol. 2010, 185:7216-7222.
206. Mildner A., Schlevogt B., Kierdorf K., Bottcher C., Erny D., Kummer M.P., Quinn M., Bruck W., Bechmann I., Heneka M.T., Priller J., Prinz M. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J. Neurosci. 2011, 31:11159-11171.
207. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.K., Mack M., Heikenwalder M., Bruck W., Priller J., Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 2007, 10:1544-1553.
208. Milligan E.D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O'Connor K.A., Verge G.M., Chapman G., Green P., Foster A.C., Naeve G.S., Maier S.F., Watkins L.R. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur. J. Neurosci. 2004, 20:2294-2302.
209. Minami S.S., Sun B., Popat K., Kauppinen T., Pleiss M., Zhou Y., Ward M.E., Floreancig P., Mucke L., Desai T., Gan L. Selective targeting of microglia by quantum dots. J. Neuroinflammation 2012, 9:22.
210. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J., Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1218.
211. Miyanishi M., Tada K., Koike M., Uchiyama Y., Kitamura T., Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007, 450:435-439.
212. Monif M., Reid C.A., Powell K.L., Smart M.L., Williams D.A. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J. Neurosci. 2009, 29:3781-3791.
213. Moore U.M., Kaplow J.M., Pleass R.D., Castro S.W., Naik K., Lynch C.N., Daly S., Roach A.G., Jaye M., Williams R.J. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B. J. Leukoc. Biol. 1997, 62:911-915.
214. Muessel M.J., Klein R.M., Wilson A.M., Berman N.E. Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules. Brain Res. Mol. Brain Res. 2002, 103:12-27.
215. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., Bendszus M., Rossetti G., Nawroth P.P., Bierhaus A., Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008, 28:12023-12031.
216. Myers S.J., Wong L.M., Charo I.F. Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J. Biol. Chem. 1995, 270:5786-5792.
217. N'Diaye E.N., Branda C.S., Branda S.S., Nevarez L., Colonna M., Lowell C., Hamerman J.A., Seaman W.E. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J. Cell Biol. 2009, 184:215-223.
218. Naert G., Rivest S. Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. Mol. Med. 2012, 18:297-313.
219. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 2008, 8:34-47.
220. Nishiyori A., Minami M., Ohtani Y., Takami S., Yamamoto J., Kawaguchi N., Kume T., Akaike A., Satoh M. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?. FEBS Lett. 1998, 429:167-172.
221. Noda M., Doi Y., Liang J., Kawanokuchi J., Sonobe Y., Takeuchi H., Mizuno T., Suzumura A. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 2011, 286:2308-2319.
222. Nomiyama H., Mera A., Ohneda O., Miura R., Suda T., Yoshie O. Organization of the chemokine genes in the human and mouse major clusters of CC and CXC chemokines: diversification between the two species. Genes Immunol. 2001, 2:110-113.
223. Ohsawa K., Irino Y., Nakamura Y., Akazawa C., Inoue K., Kohsaka S. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 2007, 55:604-616.
224. Ohsawa K., Irino Y., Sanagi T., Nakamura Y., Suzuki E., Inoue K., Kohsaka S. P2Y12 receptor-mediated integrin-beta1 activation regulates microglial process extension induced by ATP. Glia 2010, 58:790-801.
225. Ohsawa K., Sanagi T., Nakamura Y., Suzuki E., Inoue K., Kohsaka S. Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration. J. Neurochem. 2012, 121:217-227.
226. Ohtani Y., Minami M., Kawaguchi N., Nishiyori A., Yamamoto J., Takami S., Satoh M. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci. Lett. 1998, 249:163-166.
227. Oldenborg P.A., Gresham H.D., Lindberg F.P. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J. Exp. Med. 2001, 193:855-862.
228. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
229. Origlia N., Bonadonna C., Rosellini A., Leznik E., Arancio O., Yan S.S., Domenici L. Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex. J. Neurosci. 2010, 30:11414-11425.
230. Orr A.G., Orr A.L., Li X.J., Gross R.E., Traynelis S.F. Adenosine A(2A) receptor mediates microglial process retraction. Nat. Neurosci. 2009, 12:872-878.
231. Ortiz-Stern A., Rosales C. Cross-talk between Fc receptors and integrins. Immunol. Lett. 2003, 90:137-143.
232. Pabon M.M., Bachstetter A.D., Hudson C.E., Gemma C., Bickford P.C. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation 2011, 8:9.
233. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., Bianchin M., Bird T., Miranda R., Salmaggi A., Tranebjaerg L., Konttinen Y., Peltonen L. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
234. Park D., Tosello-Trampont A.C., Elliott M.R., Lu M., Haney L.B., Ma Z., Klibanov A.L., Mandell J.W., Ravichandran K.S. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007, 450:430-434.
235. Park J.G., Schreiber A.D. Determinants of the phagocytic signal mediated by the type IIIA Fc gamma receptor, Fc gamma RIIIA: sequence requirements and interaction with protein-tyrosine kinases. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7381-7385.
236. Park S.Y., Jung M.Y., Kim H.J., Lee S.J., Kim S.Y., Lee B.H., Kwon T.H., Park R.W., Kim I.S. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 2008, 15:192-201.
237. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 2003, 278:13309-13317.
238. Patel J.R., McCandless E.E., Dorsey D., Klein R.S. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11062-11067.
239. Peng Q., Malhotra S., Torchia J.A., Kerr W.G., Coggeshall K.M., Humphrey M.B. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal 2010, 3:ra38.
240. Pertwee R.G. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br. J. Pharmacol. 2009, 156:397-411.
241. Piccio L., Buonsanti C., Mariani M., Cella M., Gilfillan S., Cross A.H., Colonna M., Panina-Bordignon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2007, 37:1290-1301.
242. Pineda D., Ampurdanes C., Medina M.G., Serratosa J., Tusell J.M., Saura J., Planas A.M., Navarro P. Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors. Glia 2012, 60:526-540.
243. Prada I., Ongania G.N., Buonsanti C., Panina-Bordignon P., Meldolesi J. Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: continuous shuttling to and from the plasma membrane regulated by cell stimulation. Neuroscience 2006, 140:1139-1148.
244. Pradillo J.M., Fernandez-Lopez D., Garcia-Yebenes I., Sobrado M., Hurtado O., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem. 2009, 109:287-294.
245. Preston S., Wright G.J., Starr K., Barclay A.N., Brown M.H. The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur. J. Immunol. 1997, 27:1911-1918.
246. Puente Navazo M.D., Daviet L., Ninio E., McGregor J.L. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler. Thromb. Vasc. Biol. 1996, 16:1033-1039.
247. Qu W.S., Wang Y.H., Wang J.P., Tang Y.X., Zhang Q., Tian D.S., Yu Z.Y., Xie M.J., Wang W. Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem. Res. 2010, 35:1716-1724.
248. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
249. Raouf R., Chabot-Dore A.J., Ase A.R., Blais D., Seguela P. Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. Neuropharmacology 2007, 53:496-504.
250. Rappert A., Bechmann I., Pivneva T., Mahlo J., Biber K., Nolte C., Kovac A.D., Gerard C., Boddeke H.W., Nitsch R., Kettenmann H. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 2004, 24:8500-8509.
251. Rappert A., Biber K., Nolte C., Lipp M., Schubel A., Lu B., Gerard N.P., Gerard C., Boddeke H.W., Kettenmann H. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J. Immunol. 2002, 168:3221-3226.
252. Ravichandran K.S. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 2011, 35:445-455.
253. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci. 2009, 29:11982-11992.
254. Ren Y., Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J. Immunol. 1995, 154:2366-2374.
255. Rogers J.T., Morganti J.M., Bachstetter A.D., Hudson C.E., Peters M.M., Grimmig B.A., Weeber E.J., Bickford P.C., Gemma C. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 2011, 31:16241-16250.
256. Rosenzweig H.L., Planck S.R., Rosenbaum J.T. NLRs in immune privileged sites. Curr. Opin. Pharmacol. 2011, 11:423-428.
257. Rotshenker S. Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J. Mol. Neurosci. 2003, 21:65-72.
258. Rottman J.B., Ganley K.P., Williams K., Wu L., Mackay C.R., Ringler D.J. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 1997, 151:1341-1351.
259. Saini V., Marchese A., Majetschak M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J. Biol. Chem. 2010, 285:15566-15576.
260. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., Rivera J., Samelson L.E. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 2000, 12:525-535.
261. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
262. Sanz J.M., Di Virgilio F. Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J. Immunol. 2000, 164:4893-4898.
263. Sasaki Y., Hoshi M., Akazawa C., Nakamura Y., Tsuzuki H., Inoue K., Kohsaka S. Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia 2003, 44:242-250.
264. Satoh K., Niwa M., Goda W., Binh N.H., Nakashima M., Takamatsu M., Hara A. Galectin-3 expression in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia, and its inhibition by hypothermia. Brain Res. 2011, 1382:266-274.
265. Saura J., Angulo E., Ejarque A., Casado V., Tusell J.M., Moratalla R., Chen J.F., Schwarzschild M.A., Lluis C., Franco R., Serratosa J. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 2005, 95:919-929.
266. Savarin-Vuaillat C., Ransohoff R.M. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?. Neurotherapeutics 2007, 4:590-601.
267. Savill J., Hogg N., Ren Y., Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 1992, 90:1513-1522.
268. Schilling M., Strecker J.K., Ringelstein E.B., Schabitz W.R., Kiefer R. The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res. 2009, 1289:79-84.
269. Schmid C.D., Sautkulis L.N., Danielson P.E., Cooper J., Hasel K.W., Hilbush B.S., Sutcliffe J.G., Carson M.J. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J. Neurochem. 2002, 83:1309-1320.
270. Schwab J.M., Guo L., Schluesener H.J. Spinal cord injury induces early and persistent lesional P2X4 receptor expression. J. Neuroimmunol. 2005, 163:185-189.
271. Schwab M.E., Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 1996, 76:319-370.
272. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006, 7:311-317.
273. Sessa G., Podini P., Mariani M., Meroni A., Spreafico R., Sinigaglia F., Colonna M., Panina P., Meldolesi J. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur. J. Neurosci. 2004, 20:2617-2628.
274. Shahabuddin S., Ji R., Wang P., Brailoiu E., Dun N., Yang Y., Aksoy M.O., Kelsen S.G. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am. J. Physiol. Cell Physiol. 2006, 291:C34-C39.
275. Shaikh S.B., Uy B., Perera A., Nicholson L.F. AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem. Int. 2012, 60:640-651.
276. Sheehan J.J., Zhou C., Gravanis I., Rogove A.D., Wu Y.P., Bogenhagen D.F., Tsirka S.E. Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice. J. Neurosci. 2007, 27:1738-1745.
277. Shideman C.R., Hu S., Peterson P.K., Thayer S.A. CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. J. Neurosci. Res. 2006, 83:1471-1484.
278. Shieh J.T., Albright A.V., Sharron M., Gartner S., Strizki J., Doms R.W., Gonzalez-Scarano F. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J. Virol. 1998, 72:4243-4249.
279. Shiratori M., Tozaki-Saitoh H., Yoshitake M., Tsuda M., Inoue K. P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways. J. Neurochem. 2010, 114:810-819.
280. Sieger D., Peri F. Animal models for studying microglia: the first, the popular, and the new. Glia 2013, 61:3-9.
281. Sivakumar V., Foulds W.S., Luu C.D., Ling E.A., Kaur C. Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J. Pathol. 2011, 224:245-260.
282. Skuljec J., Sun H., Pul R., Benardais K., Ragancokova D., Moharregh-Khiabani D., Kotsiari A., Trebst C., Stangel M. CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell. Immunol. 2011, 270:164-171.
283. Smit M.J., Verdijk P., van der Raaij-Helmer E.M., Navis M., Hensbergen P.J., Leurs R., Tensen C.P. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 2003, 102:1959-1965.
284. Song X., Shapiro S., Goldman D.L., Casadevall A., Scharff M., Lee S.C. Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infect. Immun. 2002, 70:5177-5184.
285. Song X., Tanaka S., Cox D., Lee S.C. Fcgamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J. Leukoc. Biol. 2004, 75:1147-1155.
286. Sparvero L.J., Asafu-Adjei D., Kang R., Tang D., Amin N., Im J., Rutledge R., Lin B., Amoscato A.A., Zeh H.J., Lotze M.T. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 2009, 7:17.
287. Starossom S.C., Mascanfroni I.D., Imitola J., Cao L., Raddassi K., Hernandez S.F., Bassil R., Croci D.O., Cerliani J.P., Delacour D., Wang Y., Elyaman W., Khoury S.J., Rabinovich G.A. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012, 37:249-263.
288. Stefano L., Racchetti G., Bianco F., Passini N., Gupta R.S., Panina Bordignon P., Meldolesi J. The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J. Neurochem. 2009, 110:284-294.
289. Sugimoto K., Nishioka R., Ikeda A., Mise A., Takahashi H., Yano H., Kumon Y., Ohnishi T., Tanaka J. Activated microglia in a rat stroke model express NG2 proteoglycan in peri-infarct tissue through the involvement of TGF-beta1. Glia 2014, 62:185-198.
290. Suzuki J., Umeda M., Sims P.J., Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010, 468:834-838.
291. Syam S., Mero P., Pham T., McIntosh C.A., Bruhns P., Booth J.W. Differential recruitment of activating and inhibitory Fc gamma RII during phagocytosis. J. Immunol. 2010, 184:2966-2973.
292. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201:647-657.
293. Takegahara N., Takamatsu H., Toyofuku T., Tsujimura T., Okuno T., Yukawa K., Mizui M., Yamamoto M., Prasad D.V., Suzuki K., Ishii M., Terai K., Moriya M., Nakatsuji Y., Sakoda S., Sato S., Akira S., Takeda K., Inui M., Takai T., Ikawa M., Okabe M., Kumanogoh A., Kikutani H. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 2006, 8:615-622.
294. Takenouchi T., Iwamaru Y., Sugama S., Sato M., Hashimoto M., Kitani H. Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway. J. Immunol. 2008, 180:7827-7839.
295. Takenouchi T., Sato M., Kitani H. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J. Neurochem. 2007, 102:1518-1532.
296. Takenouchi T., Sugama S., Iwamaru Y., Hashimoto M., Kitani H. Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells. Crit. Rev. Immunol. 2009, 29:335-345.
297. Tanabe S., Heesen M., Yoshizawa I., Berman M.A., Luo Y., Bleul C.C., Springer T.A., Okuda K., Gerard N., Dorf M.E. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J. Immunol. 1997, 159:905-911.
298. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13798-13803.
299. Taylor N., Jahn T., Smith S., Lamkin T., Uribe L., Liu Y., Durden D.L., Weinberg K. Differential activation of the tyrosine kinases ZAP-70 and Syk after Fc gamma RI stimulation. Blood 1997, 89:388-396.
300. Tchilibon S., Joshi B.V., Kim S.K., Duong H.T., Gao Z.G., Jacobson K.A. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. J. Med. Chem. 2005, 48:1745-1758.
301. Terashima Y., Onai N., Murai M., Enomoto M., Poonpiriya V., Hamada T., Motomura K., Suwa M., Ezaki T., Haga T., Kanegasaki S., Matsushima K. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat. Immunol. 2005, 6:827-835.
302. Thored P., Heldmann U., Gomes-Leal W., Gisler R., Darsalia V., Taneera J., Nygren J.M., Jacobsen S.E., Ekdahl C.T., Kokaia Z., Lindvall O. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 2009, 57:835-849.
303. Thrash J.C., Torbett B.E., Carson M.J. Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem. Res. 2009, 34:38-45.
304. Toyomitsu E., Tsuda M., Yamashita T., Tozaki-Saitoh H., Tanaka Y., Inoue K. CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signal. 2012, 8:301-310.
305. Tridandapani S., Lyden T.W., Smith J.L., Carter J.E., Coggeshall K.M., Anderson C.L. The adapter protein LAT enhances fcgamma receptor-mediated signal transduction in myeloid cells. J. Biol. Chem. 2000, 275:20480-20487.
306. Trigatti B., Rayburn H., Vinals M., Braun A., Miettinen H., Penman M., Hertz M., Schrenzel M., Amigo L., Rigotti A., Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9322-9327.
307. Trincavelli M.L., Melani A., Guidi S., Cuboni S., Cipriani S., Pedata F., Martini C. Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J. Neurochem. 2008, 104:479-490.
308. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
309. Tsiperson V., Li X., Schwartz G.J., Raine C.S., Shafit-Zagardo B. GAS6 enhances repair following cuprizone-induced demyelination. PLoS ONE 2010, 5:e15748.
310. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., Mack M., Charo I.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 2007, 117:902-909.
311. Tsuda M., Masuda T., Kitano J., Shimoyama H., Tozaki-Saitoh H., Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:8032-8037.
312. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783.
313. Tsuda M., Toyomitsu E., Komatsu T., Masuda T., Kunifusa E., Nasu-Tada K., Koizumi S., Yamamoto K., Ando J., Inoue K. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 2008, 56:579-585.
314. Tsuda M., Toyomitsu E., Kometani M., Tozaki-Saitoh H., Inoue K. Mechanisms underlying fibronectin-induced up-regulation of P2X4R expression in microglia: distinct roles of PI3K-Akt and MEK-ERK signalling pathways. J. Cell. Mol. Med. 2009, 13:3251-3259.
315. Tsuda M., Tozaki-Saitoh H., Masuda T., Toyomitsu E., Tezuka T., Yamamoto T., Inoue K. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008, 56:50-58.
316. Tyurin V.A., Tyurina Y.Y., Feng W., Mnuskin A., Jiang J., Tang M., Zhang X., Zhao Q., Kochanek P.M., Clark R.S., Bayir H., Kagan V.E. Mass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporine-induced apoptosis. J. Neurochem. 2008, 107:1614-1633.
317. Ueyama T., Lennartz M.R., Noda Y., Kobayashi T., Shirai Y., Rikitake K., Yamasaki T., Hayashi S., Sakai N., Seguchi H., Sawada M., Sumimoto H., Saito N. Superoxide production at phagosomal cup/phagosome through beta I protein kinase C during Fc gamma R-mediated phagocytosis in microglia. J. Immunol. 2004, 173:4582-4589.
318. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
319. Ulvestad E., Williams K., Matre R., Nyland H., Olivier A., Antel J. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J. Neuropathol. Exp. Neurol. 1994, 53:27-36.
320. van der Putten C., Zuiderwijk-Sick E.A., van Straalen L., de Geus E.D., Boven L.A., Kondova I., AP I.J., Bajramovic J.J. Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. J. Immunol. 2009, 182:7603-7612.
321. van Weering H.R., Boddeke H.W., Vinet J., Brouwer N., de Haas A.H., van Rooijen N., Thomsen A.R., Biber K.P. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus 2011, 21:220-232.
322. Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 2007, 446:1023-1029.
323. Vedeler C., Ulvestad E., Grundt I., Conti G., Nyland H., Matre R., Pleasure D. Fc receptor for IgG (FcR) on rat microglia. J. Neuroimmunol. 1994, 49:19-24.
324. Verloes A., Maquet P., Sadzot B., Vivario M., Thiry A., Franck G. Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia. J. Med. Genet. 1997, 34:753-757.
325. Wang X., Li C., Chen Y., Hao Y., Zhou W., Chen C., Yu Z. Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem. Biophys. Res. Commun. 2008, 371:283-288.
326. Wang Y., Huang J., Li Y., Yang G.Y. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr. Drug Targets 2012, 13:166-172.
327. Wei Y.S., Lan Y., Meng L.Q., Nong L.G. The association of L-selectin polymorphisms with L-selectin serum levels and risk of ischemic stroke. J. Thromb. Thrombolysis 2011, 32:110-115.
328. Weinger J.G., Brosnan C.F., Loudig O., Goldberg M.F., Macian F., Arnett H.A., Prieto A.L., Tsiperson V., Shafit-Zagardo B. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis. J. Neuroinflammation 2011, 8:49.
329. Wilkinson B., Koenigsknecht-Talboo J., Grommes C., Lee C.Y., Landreth G. Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J. Biol. Chem. 2006, 281:20842-20850.
330. Wittendorp M.C., Boddeke H.W., Biber K. Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes. Glia 2004, 46:410-418.
331. Witting A., Muller P., Herrmann A., Kettenmann H., Nolte C. Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition. J. Neurochem. 2000, 75:1060-1070.
332. Wixey J.A., Reinebrant H.E., Carty M.L., Buller K.M. Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain. J. Neuroimmunol. 2009, 212:35-43.
333. Wollmer M.A., Lucius R., Wilms H., Held-Feindt J., Sievers J., Mentlein R. ATP and adenosine induce ramification of microglia in vitro. J. Neuroimmunol. 2001, 115:19-27.
334. Wong W.T. Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front. Cell. Neurosci. 2013, 7:22.
335. Woo M.S., Wang X., Faustino J.V., Derugin N., Wendland M.F., Zhou P., Iadecola C., Vexler Z.S. Genetic deletion of CD36 enhances injury after acute neonatal stroke. Ann. Neurol. 2012, 72:961-970.
336. Wright G.J., Puklavec M.J., Willis A.C., Hoek R.M., Sedgwick J.D., Brown M.H., Barclay A.N. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000, 13:233-242.
337. Wynne A.M., Henry C.J., Huang Y., Cleland A., Godbout J.P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 2010, 24:1190-1201.
338. Xiao H., Li Y., Du J., Mosig A. Ct3d: tracking microglia motility in 3D using a novel cosegmentation approach. Bioinformatics 2011, 27:564-571.
339. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
340. Yao H., Yang Y., Kim K.J., Bethel-Brown C., Gong N., Funa K., Gendelman H.E., Su T.P., Wang J.Q., Buch S. Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. Blood 2010, 115:4951-4962.
341. Yao Y., Tsirka S.E. The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency. J. Biol. Chem. 2010, 285:31509-31516.
342. Yao Y., Tsirka S.E. The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage. Glia 2012, 60:908-918.
343. Yu L., Huang Z., Mariani J., Wang Y., Moskowitz M., Chen J.F. Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat. Med. 2004, 10:1081-1087.
344. Zendedel A., Nobakht M., Bakhtiyari M., Beyer C., Kipp M., Baazm M., Joghataie M.T. Stromal cell-derived factor-1 alpha (SDF-1alpha) improves neural recovery after spinal cord contusion in rats. Brain Res. 2012, 1473:214-226.
345. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 2007, 27:12396-12406.
346. Zhang L., Liu W., Alizadeh D., Zhao D., Farrukh O., Lin J., Badie S.A., Badie B. S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway. Glia 2011, 59:486-498.
347. Zhang S., Cherwinski H., Sedgwick J.D., Phillips J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 2004, 173:6786-6793.
348. Zhang S., Phillips J.H. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J. Leukoc. Biol. 2006, 79:363-368.
349. Zhang S., Wang X.J., Tian L.P., Pan J., Lu G.Q., Zhang Y.J., Ding J.Q., Chen S.D. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J. Neuroinflammation 2011, 8:154.
350. Zhao X., Grotta J., Gonzales N., Aronowski J. Hematoma resolution as a therapeutic target: the role of microglia/macrophages. Stroke 2009, 40:S92-S94.
351. Zhao X., Sun G., Zhang J., Strong R., Song W., Gonzales N., Grotta J.C., Aronowski J. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann. Neurol. 2007, 61:352-362.
352. Zhuang Z.Y., Kawasaki Y., Tan P.H., Wen Y.R., Huang J., Ji R.R. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav. Immun. 2007, 21:642-651.
353. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.